Clinical trial Recruiting at 3 sites Interventional Ages 7 to 15

Personalized tools to help students with reading difficulties

Official title: Efficacy of the Personalization of Visual Parameters and Text-to-Speech to Improve Reading Speed, Accuracy and Comprehension in Students With Learning Disorders

Run by IRCCS Eugenio Medea · NCT06947512 · Data updated 2026-11-12

This study is testing a new online tool that helps students with reading difficulties, especially those with dyslexia, by letting them customize how text looks and sounds to see if it improves their reading and writing skills.

Quick facts

Study typeInterventional
Ages7 Years to 15 Years
SexAll
Enrollment200 (estimated)
SponsorIRCCS Eugenio Medea
Academic / other
Locations3 sites (Bosisio Parini, LC and 2 other locations)
StatusRecruiting
StartedFebruary 16, 2023
Main results expectedDecember 2026
Study endsDecember 31, 2026
Registry record updatedNovember 5, 2026
Trial IDNCT06947512 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are students aged 7-15 years diagnosed with developmental dyslexia or specific reading disorders attending school in Italy.

Probably not a fit

Patients with intellectual disabilities or those without reading difficulties will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on developing a personalized approach to assist students with reading difficulties, particularly those with developmental dyslexia. It utilizes an online platform called Seleggo, which allows students to customize text visualization and text-to-speech (TTS) parameters to enhance their reading experience. The effectiveness of personalized settings will be evaluated by comparing reading and writing performance using customized versus standard fonts and voices. The goal is to identify the optimal combinations of visual and auditory parameters that facilitate learning for each individual student.

Why it matters

Potential benefit: If successful, this approach could significantly improve reading comprehension and learning outcomes for students with reading difficulties.

How similar studies have gone: Other studies have shown promise in using personalized educational tools for dyslexia, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (for TD group):

* age 7-15 years
* no history of reading difficulties
* attends school in Italy

Exclusion Criteria (for TD group):

* special educational needs or diagnosis of neurodevelopmental disorders

Inclusion Criteria (for DD group):

* age 7-15 years
* diagnosis of Developmental Dyslexia or Specific Reading Disorder
* Attends school in Italy

Exclusion Criteria (for DD group):

* diagnosis of Intellectual Disability

Inclusion Criteria (for SEN group):

* age 7-15 years
* reported by school to have significant difficulties in reading and writing
* Attends school in Italy (at least 6 months continued schooling and exposure to the Italian language)

Exclusion Criteria (for SEN group):

* diagnosis of Intellectual Disability

Where it's running

  • IRCCS E. Medea, polo di Bosisio Parini
    Bosisio Parini, Lc, Italy
    Recruiting
  • IRCCS E.Medea, polo di Conegliano
    Conegliano, Tv, Italy
    Recruiting
  • Associazione La Nostra Famiglia
    Treviso, Tv, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Assessing language and reading disorder risks in children

    This study is testing new online tools to see if they can help identify preschool and primary school kids at risk for language and learning disorders, especially those who speak multiple languages.

    Recruiting IRCCS Eugenio Medea · Bosisio Parini, LC · NCT06937255

  • Improving reading comprehension through knowledge retrieval techniques

    This study is testing a new way to help struggling readers in grades 4-6 improve their reading comprehension by using techniques that boost their ability to recall information.

    Recruiting William Jewell College · Excelsior Springs, Missouri · NCT05692973

  • How VR Can Make a Virtual Body Feel Real

    This study tests different immersive virtual reality techniques to see which best makes a person feel the virtual body as their own, including in people with spinal cord injury or stroke.

    Recruiting IRCCS Eugenio Medea · Bosisio Parini, Lecco · NCT07870044

  • Co-designed wrist-hand orthosis for children with neuromotor disorders

    In children aged 6 to 14 with neuromotor conditions after brain injury, researchers are testing a wrist-hand brace designed with input from the kids to see if it fits better and is easier to use than their current orthosis.

    Recruiting IRCCS Eugenio Medea · Bosisio Parini · NCT07861958

  • AI-based model checks how engaged a child is during rehab and how well they move

    A small pilot study tests an artificial intelligence tool that helps therapists see in real time how engaged a child is and how they move during therapy using Lokomat or GRAIL.

    Recruiting IRCCS Eugenio Medea · Bosisio Parini · NCT07664033

  • I-TOPS: Italian online problem-solving program for young people with genetic syndromes

    This project will test whether an Italian-adapted, web-based problem-solving program (I-TOPS) with parent participation can help adolescents and young adults (ages 11–39) with genetic syndromes improve planning, self-regulation, and communication in daily life.

    Recruiting IRCCS Eugenio Medea · Bosisio Parini, Lecco · NCT07563218

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.